Article info
PDFLetter
Response to: A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum?
- Correspondence to Dr David V Glidden, Epidemiology and Biostatistics, University of California, 550 16th Street, San Francisco, CA 94158, USA; David.Glidden{at}ucsf.edu
Citation
Response to: A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum?
Publication history
- Received March 29, 2017
- Accepted March 30, 2017
- First published April 13, 2017.
Online issue publication
September 06, 2017
Article Versions
- Previous version (20 July 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/